Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 25 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Conditions
- Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
- Locations
-
- USOR HonorHealth Phoenix, Arizona, United States
- USOR Arizona Oncology Associates Tucson, Arizona, United States
- University of California Los Angeles Medical Center Los Angeles, California, United States
- University of California, San Diego; Moores Cancer Center San Diego, California, United States
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
NCT04517838
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +3 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT06401889
- Conditions
- Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +15 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07122713
- Conditions
- Breast Adenocarcinoma, Breast Cancer, Breast Diseases, +5 more
- Locations
-
- Stony Brook University Cancer Center Stony Brook, New York, United States
NCT01730833
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
NCT02530489
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03106415
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT03094052
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT03250676
- Conditions
- Breast Adenocarcinoma, Breast Cancer, Breast Cancer Female, +10 more
- Locations
-
- Western Regional Medical Center, Inc., DBA Cancer Treatment Centers of America, Phoenix Goodyear, Arizona, United States
- University of California Los Angeles Los Angeles, California, United States
- University of California San Francisco San Francisco, California, United States
- University of Colorado - Cancer Center Aurora, Colorado, United States
NCT04535323
- Conditions
- Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, +32 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT04857697
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +11 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer
NCT02282345
- Conditions
- Breast Adenocarcinoma, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, +2 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00005970
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Western Regional CCOP Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
NCT00869206
- Conditions
- Blood Protein Disorders, Breast Adenocarcinoma, Breast Diseases, +35 more
- Locations
-
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- East Bay Radiation Oncology Center Castro Valley, California, United States
- Valley Medical Oncology Consultants - Castro Valley Castro Valley, California, United States
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
NCT02115282
- Conditions
- Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Adenocarcinoma, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- Mercy San Juan Medical Center Carmichael, California, United States
- Enloe Medical Center Chico, California, United States
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
NCT02957968
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +17 more
- Locations
-
- St. Elizabeth Healthcare Edgewood, Kentucky, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- University of Virginia Charlottesville, Virginia, United States
- Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
NCT02515110
- Conditions
- Breast Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
- Locations
-
- Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
- VCU Community Memorial Healthcenter South Hill, Virginia, United States
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
NCT00433511
- Conditions
- Breast Adenocarcinoma
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- Alaska Regional Hospital Anchorage, Alaska, United States